413 studies found for:    Open Studies | "Nevus"
Show Display Options
Rank Status Study
21 Recruiting Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: aminolevulinic acid hydrochloride;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: questionnaire administration
22 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
23 Unknown  Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Condition: Melanoma
Intervention:
24 Recruiting FLuorescence Identification of Melanoma by a Multicenter Based Algorithm (FLIMMA)
Conditions: Melanoma;   Moles
Intervention: Device: LIMES
25 Recruiting Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
Conditions: Burn Injury;   Soft Tissue Injury;   Skin Necrosis;   Scars;   Congenital Giant Nevus;   Skin Tumors
Interventions: Other: denovoDerm;   Other: denovoSkin
26 Recruiting Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Conditions: Choriocarcinoma;   FIGO Stage I Gestational Trophoblastic Tumor;   FIGO Stage II Gestational Trophoblastic Tumor;   FIGO Stage III Gestational Trophoblastic Tumor;   Hydatidiform Mole
Interventions: Biological: Dactinomycin;   Drug: Leucovorin Calcium;   Drug: Methotrexate;   Other: Quality-of-Life Assessment
27 Recruiting Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: No relevant intervention.
28 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
Intervention:
29 Recruiting Scalp Nerve Block on Emergence Agitation
Condition: Agitation
Interventions: Drug: Ropivacaine;   Drug: Remifentanil;   Drug: Sevoflurane
30 Recruiting Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas
Condition: Basal Cell Carcinoma
Intervention: Drug: Vismodegib
31 Recruiting Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma of the Skin;   Nevoid Basal Cell Carcinoma Syndrome;   Recurrent Skin Cancer
Interventions: Drug: Buparlisib;   Drug: Sonidegib
32 Unknown  (Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups
Conditions: Insulin Resistance;   Type 2 Diabetes Mellitus;   Cardiovascular Diseases
Intervention:
33 Recruiting GI Complications in Cancer Immunotherapy Patients
Condition: Malignant Melanoma
Intervention:
34 Recruiting Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
Condition: Melanoma
Intervention:
35 Not yet recruiting Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Condition: Desmoplastic Melanoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Procedure: Therapeutic Conventional Surgery
36 Recruiting Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Conditions: Uveal Melanoma;   Choroid Neoplasm
Intervention: Biological: ICON-1
37 Not yet recruiting Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Selumetinib
38 Recruiting A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma
Condition: Metastatic Melanoma, BRAF V600 Mutation Positive
Interventions: Drug: Cobimetinib;   Drug: Vemurafenib
39 Not yet recruiting Pembrolizumab-PET Imaging
Condition: Melanoma
Interventions: Drug: 89Zr-Pembrolizumab;   Device: 89Zr-Pembrolizumab PET
40 Recruiting In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma
Conditions: Melanoma;   Boron Neutron Capture Therapy
Intervention: Radiation: Boronophenylalanine and IHNI-based BNCT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years